Overview

Watershed Informatics provides Watershed.bio, a subscription-based platform for analyzing multi-omics data used by researchers in academia, pharmaceutical companies, and biotech firms. The platform offers a web-based interface with data analysis workflows, visualization tools, and scalable infrastructure that helps users generate basic insights and publication-quality figures with minimal coding. It differentiates itself by acting as an active partner, offering infrastructure, data science expertise, and tailored services in addition to software. Its goal is to let clients focus on discovery by handling data processing, analysis pipelines, and expert support behind the scenes.

Simplify's Take

What believers are saying

• Canvas Ventures led $14.5M Series A March 2023 for expansion.
• Bessemer and Accomplice back rapid biopharma workflow prototyping.
• $12.7M prior funding signals strong multi-omics investor confidence.

What critics are saying

• Open-source Galaxy, Nextflow erode academic pricing power now.
• AWS, Azure bundle omics workflows, undercut cloud value in 18 months.
• No Series B since 2023 depletes runway by mid-2027.

What makes Watershed Informatics unique

• Omics Bench unifies multi-omics tools for biologists without coding.
• Platform processes 300TB data monthly, cuts analysis time 86%.
• 100+ templates enable publication-quality figures in one day.

Help us improve and share your feedback! Did you find this helpful?

YesNo

Funding

Total Funding

$16.2M

Below

Industry Average

Funded Over

2 Rounds

Notable Investors:

Bessemer Venture Partners

Notable Investors:

Bessemer Venture Partners

$14,500,000

Series A

Mar 2023

Series A funding typically happens when a startup has a product and some customers, and now needs funding to scale. This money is usually used to grow the team, expand marketing, and improve the product. Venture capital firms are frequently the main investors here.

Series A Funding Comparison

Meet Average

Industry standards

Ind Avg. $15M

$3.7M

$5M

$8.2M

$14.5M

$15M

$30M

View all funding stages